Publications

2018

Mi X, Griffin G, Lee W, Patel S, Ohgami R, Ok CY, et al. Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations. Am J Hematol. 2018;93(11):1358-1367.
Xu R, Yallowitz A, Qin A, Wu Z, Shin DY, Kim J-, et al. Targeting skeletal endothelium to ameliorate bone loss. Nat Med. 2018;24(6):823-833.
Trindade AJ, Fan C, Bienstock B. Endoscopic resection of a rare subepithelial esophageal hamartoma. Dig Liver Dis. 2018;50(6):617.
Larimer BM, Dubois F, Bloch E, Nesti S, Placzek M, Zadra G, et al. Specific F-FDHT Accumulation in Human Prostate Cancer Xenograft Murine Models Is Facilitated by Prebinding to Sex Hormone-Binding Globulin. J Nucl Med. 2018;59(10):1538-1543.
Massonneau J, Ouellet C, Lucien F, Dubois CM, Tyler J, Boissonneault G. Suboptimal extracellular pH values alter DNA damage response to induced double-strand breaks. FEBS Open Bio. 2018;8(3):416-425.
Hwang I, Oh H, Santo E, Kim D-, Chen JW, Bronson RT, et al. FOXO protects against age-progressive axonal degeneration. Aging Cell. 2018;17(1).
Al-Tamari HM, Dabral S, Schmall A, Sarvari P, Ruppert C, Paik J, et al. FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis. EMBO Mol Med. 2018;10(2):276-293.
Mottahedeh J, Haffner MC, Grogan TR, Hashimoto T, Crowell PD, Beltran H, et al. CD38 is methylated in prostate cancer and regulates extracellular NAD. Cancer Metab. 2018;6:13.
Roszik J, Ring KL, Wani KM, Lazar AJ, Yemelyanova AV, Soliman PT, et al. Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy. Front Immunol. 2018;9:2102.
Kumar B, Rosenberg AZ, Choi SM, Fox-Talbot K, De Marzo AM, Nonn L, et al. Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer. Sci Rep. 2018;8(1):7189.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700